Free Trial

Stenger Family Office LLC Makes New $1.41 Million Investment in Exelon Co. (NASDAQ:EXC)

Exelon logo with Utilities background

Stenger Family Office LLC purchased a new stake in Exelon Co. (NASDAQ:EXC - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 37,542 shares of the company's stock, valued at approximately $1,413,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Rosenberg Matthew Hamilton boosted its stake in Exelon by 12.6% during the fourth quarter. Rosenberg Matthew Hamilton now owns 2,457 shares of the company's stock worth $92,000 after buying an additional 275 shares during the last quarter. Wesbanco Bank Inc. raised its holdings in shares of Exelon by 3.1% during the 4th quarter. Wesbanco Bank Inc. now owns 9,951 shares of the company's stock worth $375,000 after acquiring an additional 296 shares during the period. PFG Investments LLC boosted its position in shares of Exelon by 2.4% during the 4th quarter. PFG Investments LLC now owns 13,151 shares of the company's stock valued at $495,000 after acquiring an additional 305 shares during the last quarter. Stratos Wealth Partners LTD. grew its holdings in shares of Exelon by 1.7% in the fourth quarter. Stratos Wealth Partners LTD. now owns 18,505 shares of the company's stock valued at $697,000 after purchasing an additional 311 shares during the period. Finally, Blue Trust Inc. increased its position in Exelon by 3.0% during the fourth quarter. Blue Trust Inc. now owns 11,085 shares of the company's stock worth $450,000 after purchasing an additional 322 shares during the last quarter. 80.92% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on EXC shares. Guggenheim raised shares of Exelon from a "neutral" rating to a "buy" rating in a research note on Thursday, January 23rd. Morgan Stanley upped their target price on shares of Exelon from $46.00 to $48.00 and gave the company an "equal weight" rating in a research report on Thursday, March 20th. Barclays lifted their price objective on Exelon from $42.00 to $48.00 and gave the company an "overweight" rating in a research note on Tuesday, February 25th. Evercore ISI restated an "in-line" rating and set a $48.00 target price (up from $46.00) on shares of Exelon in a report on Tuesday. Finally, Scotiabank boosted their price target on shares of Exelon from $42.00 to $44.00 and gave the stock a "sector perform" rating in a research note on Thursday, February 13th. Five research analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $45.63.

Get Our Latest Report on Exelon

Exelon Stock Up 1.6 %

NASDAQ EXC traded up $0.75 on Friday, hitting $47.26. 7,496,103 shares of the stock were exchanged, compared to its average volume of 7,228,455. Exelon Co. has a fifty-two week low of $34.01 and a fifty-two week high of $48.11. The company has a 50-day moving average price of $44.35 and a 200-day moving average price of $40.81. The company has a market cap of $47.71 billion, a PE ratio of 19.29, a PEG ratio of 2.86 and a beta of 0.39. The company has a quick ratio of 0.78, a current ratio of 0.87 and a debt-to-equity ratio of 1.61.

Exelon (NASDAQ:EXC - Get Free Report) last posted its earnings results on Wednesday, February 12th. The company reported $0.64 EPS for the quarter, beating the consensus estimate of $0.59 by $0.05. Exelon had a return on equity of 9.52% and a net margin of 10.68%. During the same period last year, the firm earned $0.60 EPS. Sell-side analysts anticipate that Exelon Co. will post 2.64 EPS for the current fiscal year.

Exelon Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were paid a $0.40 dividend. This is a positive change from Exelon's previous quarterly dividend of $0.38. This represents a $1.60 annualized dividend and a yield of 3.39%. The ex-dividend date was Monday, February 24th. Exelon's dividend payout ratio is currently 65.31%.

Insiders Place Their Bets

In other Exelon news, EVP Colette D. Honorable sold 1,463 shares of the firm's stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $40.57, for a total transaction of $59,353.91. Following the transaction, the executive vice president now owns 2,271 shares of the company's stock, valued at approximately $92,134.47. This trade represents a 39.18 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.10% of the stock is owned by corporate insiders.

Exelon Profile

(Free Report)

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.

Featured Stories

Institutional Ownership by Quarter for Exelon (NASDAQ:EXC)

Should You Invest $1,000 in Exelon Right Now?

Before you consider Exelon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.

While Exelon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market
Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines